United Therapeutics has scored a regulatory green light to start clinical trials for its genetically modified pig kidneys to ...

A New Hampshire man fought for the chance at a pig kidney transplant, spending months getting into good enough shape to be ...

His effort paid off: Tim Andrews, 66, is only the second person known to be living with a pig kidney. Andrews is free from ...

UBS lowered the firm’s price target on United Therapeutics (UTHR) to $460 from $475 and keeps a Buy rating on the shares. United Therapeutics ...

For 66-year-old Tim Andrews, it was a matter of life or death. Andrews had spent the better part of two years on dialysis because of end-stage kidney disease. He was on the transplant wait list for a ...

The U.S. Food and Drug Administration has approved the first-ever clinical trials testing pig kidney transplants in people ...

United Therapeutics (UTHR) announced full enrollment of the TETON 1 study evaluating the use of Tyvaso or treprostinil, inhalation solution or ...

United Therapeutics said the FDA has cleared it to begin the first clinical trial testing whether organs from gene-edited ...

Kingswood Wealth Advisors LLC bought a new position in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) during ...

The US Food and Drug Administration approved clinical trials that will transplant organs from genetically modified pigs into ...